Stay updated on SKI-G-801 Dose Study in AML Clinical Trial
Sign up to get notified when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.

Latest updates to the SKI-G-801 Dose Study in AML Clinical Trial page
- Check6 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.9%
- Check13 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference1.0%
- Check20 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.SummaryDifference0.1%
- Check29 days agoChange DetectedThe web page has been updated to version 2.16.10, and a service alert regarding planned maintenance has been removed.SummaryDifference1%
- Check36 days agoChange DetectedThe page has been updated to reflect a new version, changing from v2.16.6 to v2.16.8, and includes a new section on HHS Vulnerability Disclosure.SummaryDifference1%
- Check43 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference1.0%
Stay in the know with updates to SKI-G-801 Dose Study in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.